381 related articles for article (PubMed ID: 17634949)
1. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Launay-Vacher V; Oudard S; Janus N; Gligorov J; Pourrat X; Rixe O; Morere JF; Beuzeboc P; Deray G;
Cancer; 2007 Sep; 110(6):1376-84. PubMed ID: 17634949
[TBL] [Abstract][Full Text] [Related]
2. Drug management of prostate cancer: prevalence and consequences of renal insufficiency.
Launay-Vacher V; Ayllon J; Janus N; Spano JP; Ray-Coquard I; Gligorov J; Pourrat X; Morere JF; Beuzeboc P; Deray G; Oudard S;
Clin Genitourin Cancer; 2009 Oct; 7(3):E83-9. PubMed ID: 19815487
[TBL] [Abstract][Full Text] [Related]
3. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
Karie S; Gandjbakhch F; Janus N; Launay-Vacher V; Rozenberg S; Mai Ba CU; Bourgeois P; Deray G
Rheumatology (Oxford); 2008 Mar; 47(3):350-4. PubMed ID: 18238787
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Launay-Vacher V; Gligorov J; Le Tourneau C; Janus N; Spano JP; Ray-Coquard I; Oudard S; Pourrat X; Morere JF; Deray G; Beuzeboc P;
Breast Cancer Res Treat; 2010 Dec; 124(3):745-53. PubMed ID: 18704681
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Launay-Vacher V; Etessami R; Janus N; Spano JP; Ray-Coquard I; Oudard S; Gligorov J; Pourrat X; Beuzeboc P; Deray G; Morere JF;
Lung; 2009; 187(1):69-74. PubMed ID: 18941834
[TBL] [Abstract][Full Text] [Related]
6. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients.
Launay-Vacher V; Izzedine H; Rey JB; Rixe O; Chapalain S; Nourdine S; Paci A; Bourget P; Deray G
Med Sci Monit; 2004 May; 10(5):CR209-12. PubMed ID: 15114271
[TBL] [Abstract][Full Text] [Related]
7. Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study.
Launay-Vacher V; Spano JP; Janus N; Gligorov J; Ray-Coquard I; Oudard S; Pourrat X; Morere JF; Beuzeboc P; Deray G;
Crit Rev Oncol Hematol; 2009 May; 70(2):124-33. PubMed ID: 18990585
[TBL] [Abstract][Full Text] [Related]
8. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.
Rashid ST; Salman M; Agarwal S; Hamilton G
Eur J Vasc Endovasc Surg; 2006 Sep; 32(3):294-9. PubMed ID: 16716614
[TBL] [Abstract][Full Text] [Related]
9. Importance of monitoring renal function in patients with cancer.
Aapro M; Launay-Vacher V
Cancer Treat Rev; 2012 May; 38(3):235-40. PubMed ID: 21605937
[TBL] [Abstract][Full Text] [Related]
10. Are antibiotic drugs well prescribed in case of renal insufficiency? A retrospective study.
Arlicot N; Pourrat X; Bourgoin-Hérard H; Grassin J; Antier D
Ren Fail; 2007; 29(8):1055-8. PubMed ID: 18067057
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group.
Launay-Vacher V
Semin Nephrol; 2010 Nov; 30(6):548-56. PubMed ID: 21146120
[TBL] [Abstract][Full Text] [Related]
12. [Renal insufficiency and breast cancer].
Beuzeboc P; Le Tourneau C; Gligorov J; Janus N; Spano JP; Ray-Coquard I; Deray G; Launay-Vacher V
Bull Cancer; 2012 Mar; 99(3):309-15. PubMed ID: 22106161
[TBL] [Abstract][Full Text] [Related]
13. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency.
Lichtman SM; Wildiers H; Launay-Vacher V; Steer C; Chatelut E; Aapro M
Eur J Cancer; 2007 Jan; 43(1):14-34. PubMed ID: 17222747
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.
Déti EK; Thiébaut R; Bonnet F; Lawson-Ayayi S; Dupon M; Neau D; Pellegrin JL; Malvy D; Tchamgoué S; Dabis F; Morlat P;
HIV Med; 2010 May; 11(5):308-17. PubMed ID: 20002500
[TBL] [Abstract][Full Text] [Related]
15. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score.
Dudek D; Chyrchel B; Siudak Z; Depukat R; Chyrchel M; Dziewierz A; Mielecki W; Rakowski T; Rzeszutko Ł; Dubiel J
Kardiol Pol; 2008 Jan; 66(1):28-34; discussion 35-6. PubMed ID: 18266185
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
17. [Is assessment of kidney involvement in patients with essential hypertension satisfactory? General medical observation results in a national study (PHENOMEN)].
Mounier-Vehier C; Amah G; Duquenoy S; Fontaine P; Phan TM
Arch Mal Coeur Vaiss; 2003; 96(7-8):792-5. PubMed ID: 12945226
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States.
Arellano J; Hernandez RK; Wade SW; Chen K; Pirolli M; Quach D; Quigley J; Liede A; Shahinian VB
Cancer Med; 2015 May; 4(5):713-20. PubMed ID: 25663171
[TBL] [Abstract][Full Text] [Related]
19. [Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G; Máthé C; Müller V; Szondy K; Moldvay J
Magy Onkol; 2010 Dec; 54(4):289-96. PubMed ID: 21163759
[TBL] [Abstract][Full Text] [Related]
20. Cancer and renal insufficiency results of the BIRMA study.
Janus N; Launay-Vacher V; Byloos E; Machiels JP; Duck L; Kerger J; Wynendaele W; Canon JL; Lybaert W; Nortier J; Deray G; Wildiers H
Br J Cancer; 2010 Dec; 103(12):1815-21. PubMed ID: 21063408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
